Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy

10.1186/s12943-015-0391-4

Saved in:

Bibliographic Details
Main Authors:	Ling L., Tan S.K., Goh T.H., Cheung E., VICTOR NURCOMBE, van Wijnen A.J., Cool S.M.
Other Authors:	BIOCHEMISTRY
Format:	Article
Published:	BioMed Central Ltd. 2020
Subjects:	1 tert butyl 3 [6 (3,5 dimethoxyphenyl) 2 (4 diethylaminobutylamino)pyrido[2,3 d]pyrimidin 7 yl]urea 3 [4 methyl 2 (2 oxo 3 indolinylmethylidenyl) 3 pyrrolyl]propionic acid antibodies,antisera and immunoglobulins antineoplastic agent fibroblast growth factor receptor 1 heparan sulfate heparin binding protein imb r1 phospholipase C gamma protein p53 unclassified drug fibroblast growth factor 2 heparin messenger RNA monoclonal antibody antioxidant assay apoptosis Article cancer survival cell survival controlled study cross reaction down regulation drug protein binding enzyme activation enzyme linked immunosorbent assay human human cell immunohistochemistry methodology proof of concept study protein domain protein targeting quantitative analysis real time polymerase chain reaction sequence homology signal transduction Student t test upregulation Western blotting antagonists and inhibitors biopsy cell proliferation chemistry drug effects gene expression regulation genetics metabolism molecularly targeted therapy Neoplasms pathology Antibodies, Monoclonal Antineoplastic Agents Apoptosis Biopsy Cell Proliferation Fibroblast Growth Factor 2 Gene Expression Regulation, Neoplastic Heparin Humans Molecular Targeted Therapy Protein Interaction Domains and Motifs Receptor, Fibroblast Growth Factor, Type 1 RNA, Messenger Signal Transduction
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/174283
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-174283
record_format	dspace
spelling	sg-nus-scholar.10635-1742832024-04-18T07:32:45Z Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy Ling L. Tan S.K. Goh T.H. Cheung E. VICTOR NURCOMBE van Wijnen A.J. Cool S.M. BIOCHEMISTRY ORTHOPAEDIC SURGERY 1 tert butyl 3 [6 (3,5 dimethoxyphenyl) 2 (4 diethylaminobutylamino)pyrido[2,3 d]pyrimidin 7 yl]urea 3 [4 methyl 2 (2 oxo 3 indolinylmethylidenyl) 3 pyrrolyl]propionic acid antibodies,antisera and immunoglobulins antineoplastic agent fibroblast growth factor receptor 1 heparan sulfate heparin binding protein imb r1 phospholipase C gamma protein p53 unclassified drug antineoplastic agent fibroblast growth factor 2 fibroblast growth factor receptor 1 heparin messenger RNA monoclonal antibody antioxidant assay apoptosis Article cancer survival cell survival controlled study cross reaction down regulation drug protein binding enzyme activation enzyme linked immunosorbent assay human human cell immunohistochemistry methodology proof of concept study protein domain protein targeting quantitative analysis real time polymerase chain reaction sequence homology signal transduction Student t test upregulation Western blotting antagonists and inhibitors biopsy cell proliferation chemistry drug effects gene expression regulation genetics metabolism molecularly targeted therapy Neoplasms pathology protein domain Antibodies, Monoclonal Antineoplastic Agents Apoptosis Biopsy Cell Proliferation Fibroblast Growth Factor 2 Gene Expression Regulation, Neoplastic Heparin Humans Molecular Targeted Therapy Neoplasms Protein Interaction Domains and Motifs Receptor, Fibroblast Growth Factor, Type 1 RNA, Messenger Signal Transduction 10.1186/s12943-015-0391-4 Molecular Cancer 14 1 136 2020-09-04T02:09:47Z 2020-09-04T02:09:47Z 2015 Article Ling L., Tan S.K., Goh T.H., Cheung E., VICTOR NURCOMBE, van Wijnen A.J., Cool S.M. (2015). Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy. Molecular Cancer 14 (1) : 136. ScholarBank@NUS Repository. https://doi.org/10.1186/s12943-015-0391-4 14764598 https://scholarbank.nus.edu.sg/handle/10635/174283 BioMed Central Ltd. Unpaywall 20200831
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	1 tert butyl 3 [6 (3,5 dimethoxyphenyl) 2 (4 diethylaminobutylamino)pyrido[2,3 d]pyrimidin 7 yl]urea 3 [4 methyl 2 (2 oxo 3 indolinylmethylidenyl) 3 pyrrolyl]propionic acid antibodies,antisera and immunoglobulins antineoplastic agent fibroblast growth factor receptor 1 heparan sulfate heparin binding protein imb r1 phospholipase C gamma protein p53 unclassified drug antineoplastic agent fibroblast growth factor 2 fibroblast growth factor receptor 1 heparin messenger RNA monoclonal antibody antioxidant assay apoptosis Article cancer survival cell survival controlled study cross reaction down regulation drug protein binding enzyme activation enzyme linked immunosorbent assay human human cell immunohistochemistry methodology proof of concept study protein domain protein targeting quantitative analysis real time polymerase chain reaction sequence homology signal transduction Student t test upregulation Western blotting antagonists and inhibitors biopsy cell proliferation chemistry drug effects gene expression regulation genetics metabolism molecularly targeted therapy Neoplasms pathology protein domain Antibodies, Monoclonal Antineoplastic Agents Apoptosis Biopsy Cell Proliferation Fibroblast Growth Factor 2 Gene Expression Regulation, Neoplastic Heparin Humans Molecular Targeted Therapy Neoplasms Protein Interaction Domains and Motifs Receptor, Fibroblast Growth Factor, Type 1 RNA, Messenger Signal Transduction
spellingShingle	1 tert butyl 3 [6 (3,5 dimethoxyphenyl) 2 (4 diethylaminobutylamino)pyrido[2,3 d]pyrimidin 7 yl]urea 3 [4 methyl 2 (2 oxo 3 indolinylmethylidenyl) 3 pyrrolyl]propionic acid antibodies,antisera and immunoglobulins antineoplastic agent fibroblast growth factor receptor 1 heparan sulfate heparin binding protein imb r1 phospholipase C gamma protein p53 unclassified drug antineoplastic agent fibroblast growth factor 2 fibroblast growth factor receptor 1 heparin messenger RNA monoclonal antibody antioxidant assay apoptosis Article cancer survival cell survival controlled study cross reaction down regulation drug protein binding enzyme activation enzyme linked immunosorbent assay human human cell immunohistochemistry methodology proof of concept study protein domain protein targeting quantitative analysis real time polymerase chain reaction sequence homology signal transduction Student t test upregulation Western blotting antagonists and inhibitors biopsy cell proliferation chemistry drug effects gene expression regulation genetics metabolism molecularly targeted therapy Neoplasms pathology protein domain Antibodies, Monoclonal Antineoplastic Agents Apoptosis Biopsy Cell Proliferation Fibroblast Growth Factor 2 Gene Expression Regulation, Neoplastic Heparin Humans Molecular Targeted Therapy Neoplasms Protein Interaction Domains and Motifs Receptor, Fibroblast Growth Factor, Type 1 RNA, Messenger Signal Transduction Ling L. Tan S.K. Goh T.H. Cheung E. VICTOR NURCOMBE van Wijnen A.J. Cool S.M. Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy
description	10.1186/s12943-015-0391-4
author2	BIOCHEMISTRY
author_facet	BIOCHEMISTRY Ling L. Tan S.K. Goh T.H. Cheung E. VICTOR NURCOMBE van Wijnen A.J. Cool S.M.
format	Article
author	Ling L. Tan S.K. Goh T.H. Cheung E. VICTOR NURCOMBE van Wijnen A.J. Cool S.M.
author_sort	Ling L.
title	Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy
title_short	Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy
title_full	Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy
title_fullStr	Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy
title_full_unstemmed	Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy
title_sort	targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy
publisher	BioMed Central Ltd.
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/174283
_version_	1800914226839027712

Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy

Similar Items